Algppt n0 v 13 11am2010

transcript

SANKALPA SANKALPA

Algae Biotechnology Algae Biotechnology

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

In the beginning…

there was algae…

…breathing oxygen into the emerging elements of our embryonic Earth,

dividing and replicating at exponential rates to create new climates,

facilitating and co-creating a world in transformation.…

…breathing oxygen into the emerging elements of our embryonic Earth,

dividing and replicating at exponential rates to create new climates,

facilitating and co-creating a world in transformation.…

Today, this ancient life-giver reappears as the core topic of commercial and environmental interest in salvaging our energy economy and our planetary future - our hope for abundant fuel, medicine, food and carbon sequestration.

Algae Financial Forecast Algae Financial Forecast

In August, 2010, Global Information released a new market research report, Algae Biofuels Production Technologies Worldwide, in which they project that the total algae biofuels production technologies market (including cultivation technology sales, harvesting, extraction and fuels production facilities) will reach $1.6

billion in 2015.

In August, 2010, Global Information released a new market research report, Algae Biofuels Production Technologies Worldwide, in which they project that the total algae biofuels production technologies market (including cultivation technology sales, harvesting, extraction and fuels production facilities) will reach $1.6

billion in 2015.

According to the study…According to the study…

“Starting at an estimated $271 million market size for 2010, this increase is significant and underscores that this is a quickly changing and evolving industry, expected to show an annual growth rate of nearly 43 percent.”

• The Fuel/Resource of the Future

• Investments

• Commercialization

• Nutraceuticals

• Process / Reactors

• Sankalpa: The Photoreactor Company / Team

• Investment / Closing

• The Fuel/Resource of the Future

• Investments

• Commercialization

• Nutraceuticals

• Process / Reactors

• Sankalpa: The Photoreactor Company / Team

• Investment / Closing

Algae Fuel Algae Fuel

The Fuel of the Future?The Fuel of the Future?

• Algae produce 100 times more oil per acre than traditional food oilseed crops such as soy etc. Algae produces 4,000 -15,000 gallons of oil per acre per year versus 50 gallons per acre for soy, or approximately 26 gallons per hectare

• Algae eat CO2, the major Global Warming Gas, and produce oxygen.

• Algae require only sunshine and water, and thrive on waste and polluted waters

• Algae do not compete with food crops for either agricultural land or fresh water.

• Algae produce 100 times more oil per acre than traditional food oilseed crops such as soy etc. Algae produces 4,000 -15,000 gallons of oil per acre per year versus 50 gallons per acre for soy, or approximately 26 gallons per hectare

• Algae eat CO2, the major Global Warming Gas, and produce oxygen.

• Algae require only sunshine and water, and thrive on waste and polluted waters

• Algae do not compete with food crops for either agricultural land or fresh water.

“If we were to replace all of the diesel that we use in the United States, with an algae derivative, we could do it on an area of land less than one half of 1% of the current farm land that we now use.”

Douglas Henston, Pres. Solix Algae Fuels

“If we were to replace all of the diesel that we use in the United States, with an algae derivative, we could do it on an area of land less than one half of 1% of the current farm land that we now use.”

Douglas Henston, Pres. Solix Algae Fuels

Diesel Fuel Diesel Fuel

Simply put, algae out-compete virtually all other methods and resources for producing

biofuel and essential nutrients.

According to the University of Washington, algae require the least amount

of crop land to meet fuel needs.

Simply put, algae out-compete virtually all other methods and resources for producing

biofuel and essential nutrients.

According to the University of Washington, algae require the least amount

of crop land to meet fuel needs.

Inputs - OutputsInputs - Outputs

InvestmentsInvestments

Investing In the Future of Fuel

• In 2007, $32 million in venture capital was pumped into businesses working on algae fuel.

• In 2008, that number reached $184 million worldwide, according to Cleantech Network, which tracks environmental industries.

Shell Oil Shell Oil

• In 2007 Shell Oil formed Cellana, a joint venture with HR Biopetroleum, which has established an open-pond salt water algae facility in Hawaii specializing in native local species.

• In September, 2008, Bill Gates' Cascade Investment and three other companies gave a total of $100 million to Sapphire Energy, a San Diego company producing fuel from algae and other microorganisms.

Bill GatesBill Gates

AviationAviation

• In November of 2008, Boeing announced the creation of the Algae Biofuel Organization, a coalition of aviation fuel users united to speed development of algae fuel.

• In 2008, Virgin Airlines ran test flights using jet fuel from algae grown on sewage water, by Aquaflow Bionics, with Jet Blue following suit.

• In November of 2008, Boeing announced the creation of the Algae Biofuel Organization, a coalition of aviation fuel users united to speed development of algae fuel.

• In 2008, Virgin Airlines ran test flights using jet fuel from algae grown on sewage water, by Aquaflow Bionics, with Jet Blue following suit.

ExxonMobil: $600 MillionExxonMobil: $600 Million

• On July 15, 2009, Exxon announced a 600 million dollar investment into algae biofuel research. The research facility is based at partner Synthetic Genomics headquarters, and opened on July 14, 2010 in La Jolla, California.

http://gigaom2.files.wordpress.com/2010/07/exxonsynthetictestsite54.jpg

• On July 15, 2009, Exxon announced a 600 million dollar investment into algae biofuel research. The research facility is based at partner Synthetic Genomics headquarters, and opened on July 14, 2010 in La Jolla, California.

http://gigaom2.files.wordpress.com/2010/07/exxonsynthetictestsite54.jpg

Solazyme: $125 MillionSolazyme: $125 Million

August 9, 2010: Seven-year-old Solazyme announced that it has raised $52 million in Series D financing from investors including

Braemer Energy Ventures, Morgan Stanley, and Chevron Technology Ventures, the VC arm of the oil giant. Including this

round, Solazyme has now raised over $125 million.

August 9, 2010: Seven-year-old Solazyme announced that it has raised $52 million in Series D financing from investors including

Braemer Energy Ventures, Morgan Stanley, and Chevron Technology Ventures, the VC arm of the oil giant. Including this

round, Solazyme has now raised over $125 million.

Commercialization TimelineCommercialization Timeline

Countdown Countdown

• There exist a divergence of opinion on the timelines for algal commercialization.

• Groups are generally in the 10-year camp or the 2-3 year

• There exist a divergence of opinion on the timelines for algal commercialization.

• Groups are generally in the 10-year camp or the 2-3 year

Ten Years?Ten Years?

• In the ten year camp we find companies such as ExxonMobil and Sapphire Energy.

• Sapphire’s commercialization path aims both short and long-term, with projections for 1 million gallons per year by 2011 to 1 billion gallons in the 2020s, while ExxonMobil’s biofuels chief Emil Jacobs has discussed algae in 10-year timelines.

• In the ten year camp we find companies such as ExxonMobil and Sapphire Energy.

• Sapphire’s commercialization path aims both short and long-term, with projections for 1 million gallons per year by 2011 to 1 billion gallons in the 2020s, while ExxonMobil’s biofuels chief Emil Jacobs has discussed algae in 10-year timelines.

Two to Three Years?Two to Three Years?

• On the other hand, according to Biofuel Digest, companies such as PetroAlgae, Algenol, Aurora and Solazyme are giving much shorter commercialization timelines.

Solazyme: 2012Solazyme: 2012

• Solazyme, which produces sugar-fed algae without photosynthesis confirmed at last year’s Advanced Biofuels Development Summit that it would expect to have its first 100 million gallon per year (or large-scale commercial) facility in operation by 2012-13.

Algenol: 2013Algenol: 2013

• Algenol’s Biofields project begins construction this year, and Biofields continues to guide the markets to expect commercial capacity by 2013 in the 250 million gallons per year range.

• Algenol CEO Paul Woods expressed to the Biofuel Digest last year that he would regard the achievement of only 300 Mgy in capacity by mid-decade as a “disappointment”. http://i.i.com.com/cnwk.1d/i/bto/20080612/algenol_270x292.GIF

• Algenol’s Biofields project begins construction this year, and Biofields continues to guide the markets to expect commercial capacity by 2013 in the 250 million gallons per year range.

• Algenol CEO Paul Woods expressed to the Biofuel Digest last year that he would regard the achievement of only 300 Mgy in capacity by mid-decade as a “disappointment”. http://i.i.com.com/cnwk.1d/i/bto/20080612/algenol_270x292.GIF

Aurora Algae: 2013Aurora Algae: 2013

• Sept 2010 - Aurora Algae CEO Greg Bafalis forecasted the company could reap $100,000 in gross revenue per acre, and plans to be in large commercial production within 30 months, quickly scaling up to 1,000-plus acres. The company is constructing a first demonstration facility in Australia. “In about two and a half years we’ll be cash flow positive,” Bafalis predicted. “We’ll be tackling private equity and venture capital in the next year.” The company has raised $40 million to date, with its third round in March, 2010, yielding $15 million. http://venturebeat.com/2010/09/13/aurora%E2%80%99s-rebranding-bets-on-protein-bars-and-lotion-not-biofuel/

• October, 2010: Aviation industry giants including British Airways and Airbus are supporting a project at the UK's Cranfield University to investigate ways of harvesting algae for jet fuel in commercial quantities. British Airways announced earlier this year it was establishing a facility in east London to convert 500,000 tonnes of waste a year into 16 million gallons of jet fuel. The airline said it would use low-carbon fuel to power part of its fleet by 2014. http://www.oilgae.com/blog/2010/10/algae-as-aviation-fuel.html

British Airways: 2014 British Airways: 2014

Algae Cultivation ProcessAlgae Cultivation Process

Simple Process: Fuel and Biomass

Simple ProcessSimple Process

Integration & Multi-Products Integration & Multi-Products

Fermentation ProcessFermentation Process

Integration with JatrophaIntegration with Jatropha

Algae Photo-ReactorsAlgae Photo-Reactors

Acrylic Tubes Acrylic Tubes

Vertical Plastic BagsVertical Plastic Bags

Flexible TubingFlexible Tubing

Seambiotic, an Israeli firm, uses raceway/paddle-wheel open-pond algae cultivation growth fed by C02 flue-gas from a nearby power plant.

Raceway and Paddle Wheel Raceway and Paddle Wheel

Photoreactor YieldsPhotoreactor Yields

• Production w Closed System • High Nutrient Input or Waste Stream• Single Species in Controlled Environment:

30,000 -100,000 gallons per year per acre

• Production w Closed System • High Nutrient Input or Waste Stream• Single Species in Controlled Environment:

30,000 -100,000 gallons per year per acre

NutraceuticalsNutraceuticals

• Algae are a rich and varied source of pharmacologically active natural products and nutraceuticals. While nutraceutical and pharmaceutical content in the baseline algae strain is very small, current market values for these products are extremely high.

• The major products currently being commercialized or under consideration for commercial extraction include carotenoids, phycobilins, fatty acids, polysaccharides, vitamins, sterols, and biologically active molecules for use in human and animal health.

• Algae are a rich and varied source of pharmacologically active natural products and nutraceuticals. While nutraceutical and pharmaceutical content in the baseline algae strain is very small, current market values for these products are extremely high.

• The major products currently being commercialized or under consideration for commercial extraction include carotenoids, phycobilins, fatty acids, polysaccharides, vitamins, sterols, and biologically active molecules for use in human and animal health.

• Algae yield omega-3 fatty acids, proteins and oils at more

profitable margins than other methods of production.

• Common species of nutritional supplements include Spirulina, Chlorella and Duniella

• Algae extracts are used for health supplements, pharmaceuticals, soaps, lotions, protein bars, shakes, and beauty products.

• Algae yield omega-3 fatty acids, proteins and oils at more

profitable margins than other methods of production.

• Common species of nutritional supplements include Spirulina, Chlorella and Duniella

• Algae extracts are used for health supplements, pharmaceuticals, soaps, lotions, protein bars, shakes, and beauty products.

Omega 3 Omega 3

Nutraceuticals per KiloNutraceuticals per Kilo

According to BioCentric, which has invested $600,000 in its line of algae nutraceuticals:

• Haemaotoccocus has a current market value of $341 per kilogram,

• Chlorella clocks in at $44 per kilo and • Spirulina sells for $20 per kilo

According to BioCentric, which has invested $600,000 in its line of algae nutraceuticals:

• Haemaotoccocus has a current market value of $341 per kilogram,

• Chlorella clocks in at $44 per kilo and • Spirulina sells for $20 per kilo

The pharmaceutical industry is growing at a CAGR of

around 8% while the global pharmaceutical market is forecasted to reach US$ 1043.4 billion in 2012.

Use of algae, especially cyanobacteria based active compounds, has received ever-increasing interest as:

• Antimicrobials, Antivirals & Antifungals• Neuroprotective Products• Therapeutic proteins• Drugs

The pharmaceutical industry is growing at a CAGR of

around 8% while the global pharmaceutical market is forecasted to reach US$ 1043.4 billion in 2012.

Use of algae, especially cyanobacteria based active compounds, has received ever-increasing interest as:

• Antimicrobials, Antivirals & Antifungals• Neuroprotective Products• Therapeutic proteins• Drugs

DOW ChemicalsDOW Chemicals

Dow Chemical's Steve Gluck notes major opportunity in the chemical industry for algae compared to biofuels.

"To get into the algae market, I think you might have to capture the chemical sector based on how much algae feedstock is needed in the chemical industry compared to the fuel refineries," said Gluck. "Chemicals need a pure material that algae can produce while fuels can have blended components.

Dow Chemical's Steve Gluck notes major opportunity in the chemical industry for algae compared to biofuels.

"To get into the algae market, I think you might have to capture the chemical sector based on how much algae feedstock is needed in the chemical industry compared to the fuel refineries," said Gluck. "Chemicals need a pure material that algae can produce while fuels can have blended components.

Green PolymersGreen Polymers

Co-products from algae, including green polymers, chemicals and animal feed, will play a decisive role in the success of established and emerging algae production ventures.

Algae as ProteinAlgae as Protein

• According to the FAO, the world protein consumption is set to increase 74 percent by 2050, surpassing the replenishment of wild and farm-raised fish and livestock populations.

• Algae can provide high-concentration EPA oils and protein extracts, and low-cost fish meal for aquaculture facilities.

• Algae production systems will play an important role in addressing the growing worldwide demand for protein and Omega-3 fatty acids while reducing overfishing.

• According to the FAO, the world protein consumption is set to increase 74 percent by 2050, surpassing the replenishment of wild and farm-raised fish and livestock populations.

• Algae can provide high-concentration EPA oils and protein extracts, and low-cost fish meal for aquaculture facilities.

• Algae production systems will play an important role in addressing the growing worldwide demand for protein and Omega-3 fatty acids while reducing overfishing.

Algae Trends Algae Trends

• Current trends in Algae production include expansion from fuels to nutritional supplements, beauty products and pharmaceuticals.

• Alameda CA (SPX) Sep 15, 2010Aurora Algae has announced its transition from pilot technology development into full-scale commercialization of the Company's proprietary algae products, including high concentration eicosapentaenoic acid (EPA Omega-3 fatty acids), high-density proteins, fish meal and renewable fuels.

• Current trends in Algae production include expansion from fuels to nutritional supplements, beauty products and pharmaceuticals.

• Alameda CA (SPX) Sep 15, 2010Aurora Algae has announced its transition from pilot technology development into full-scale commercialization of the Company's proprietary algae products, including high concentration eicosapentaenoic acid (EPA Omega-3 fatty acids), high-density proteins, fish meal and renewable fuels.

• The markets for both pharmaceuticals and nutraceuticals are growing quickly worldwide, and it is this global scope that particularly attracts marketers.

• A growing proportion of today’s promising pharmaceutical and nutraceutical research focuses on the production of promising compounds from algae. Thus, the untapped potential of algae in the field of pharmaceuticals and nutraceuticals has to be still explored to grow and capitalize on tremendous global marketing opportunities

• The markets for both pharmaceuticals and nutraceuticals are growing quickly worldwide, and it is this global scope that particularly attracts marketers.

• A growing proportion of today’s promising pharmaceutical and nutraceutical research focuses on the production of promising compounds from algae. Thus, the untapped potential of algae in the field of pharmaceuticals and nutraceuticals has to be still explored to grow and capitalize on tremendous global marketing opportunities

VisionMissionStrategyTeam

SANKALPA SANKALPA

VisionVision

Sankalpa will serve global sustainability and abundance by manufacturing machinery for tapping the unlimited

potential of algae to meet ever-increasing human needs for clean fuel, energy, food, medicine, water and CO2

sequestration. In so doing we will create a profitable means toward restoring our environment for future

generations.

Sankalpa will serve global sustainability and abundance by manufacturing machinery for tapping the unlimited

potential of algae to meet ever-increasing human needs for clean fuel, energy, food, medicine, water and CO2

sequestration. In so doing we will create a profitable means toward restoring our environment for future

generations.

MissionMission

Sankalpa’s mission is to lead the global market in the production of photoreactors and versatile extraction

machinery, applicable to an increasingly vast spectrum of useful microorganisms, in order to most cost-efficiently

produce essential products including fuel, pharmaceuticals, foods, nutritional supplements, fertilizers, fishmeal and

cosmetics.

Sankalpa’s mission is to lead the global market in the production of photoreactors and versatile extraction

machinery, applicable to an increasingly vast spectrum of useful microorganisms, in order to most cost-efficiently

produce essential products including fuel, pharmaceuticals, foods, nutritional supplements, fertilizers, fishmeal and

cosmetics.

“Integration, diversity and versatility are key values in our adaptable systems” says Sankalpa’s

CEO Sagar Sanawe.

“Integration, diversity and versatility are key values in our adaptable systems” says Sankalpa’s

CEO Sagar Sanawe.

Versatility Versatility

“The industry is in a rapid discovery phase. Our reactors will be designed to continuously absorb new efficiencies, to self-improve with plug-in and modular capacity to integrate new methods and growth media seamlessly into last generation machinery.”

“Versatility in the creation of customized reactors for specific species of microorganisms targeting end products, such as pharmaceuticals will prove more profitable, within an earlier time frame, than solely biofuels.

CEO Sagar Sanawe

“The industry is in a rapid discovery phase. Our reactors will be designed to continuously absorb new efficiencies, to self-improve with plug-in and modular capacity to integrate new methods and growth media seamlessly into last generation machinery.”

“Versatility in the creation of customized reactors for specific species of microorganisms targeting end products, such as pharmaceuticals will prove more profitable, within an earlier time frame, than solely biofuels.

CEO Sagar Sanawe

Strategic AlliancesStrategic Alliances

In partnership with Biogreen SA of South America, Sankalpa is constructing a first hybrid-reactor/pond demonstration facility on a 21 acre property in Uruguay, South America. The project will begin with one hectare ponds, along with a series of closed-reactor systems for testing adaptable equipment optimizing key strains of commercially viable algae.

Science & Engineering

Dr. Yogesh Borole Chemist Manager at the Aditya Birla Science & Technology Centre, Mumbai. Major work areas are renewable resources, chloro-chemicals, commercialization of lab processes, oleo chemicals and alternate energy systems, high pressure gases, feasibility studies for bio-fuels. Use of ultrasonic, microwave and UV reactors for organic reaction. Use of spectroscopic and chromatographic analytical techniques.

-Directed scale up /pilot plant studies -Expert in using analytical methods

Research Interests: Renewable resources: Utilization of algae, glycerol, fatty acids, cellulose, lignin etc. as feed-stocks. Catalysis/synthesis: for fine chemicals

Dr. Yogesh Borole Chemist Manager at the Aditya Birla Science & Technology Centre, Mumbai. Major work areas are renewable resources, chloro-chemicals, commercialization of lab processes, oleo chemicals and alternate energy systems, high pressure gases, feasibility studies for bio-fuels. Use of ultrasonic, microwave and UV reactors for organic reaction. Use of spectroscopic and chromatographic analytical techniques.

-Directed scale up /pilot plant studies -Expert in using analytical methods

Research Interests: Renewable resources: Utilization of algae, glycerol, fatty acids, cellulose, lignin etc. as feed-stocks. Catalysis/synthesis: for fine chemicals

ChemistryChemistry

PhotobiologyPhotobiology

Dr. Rajeshwar Prasad SinhaMicrobiologist, BioTechnologist•Associate Professor, Laboratory of Photobiology and Molecular Microbiology, Centre of Advanced Study in Botany, Banaras Hindu University, Varanasi India. Industrial Microbiology.

•Selected as an Outstanding Scientist of the 21st century by International Biographical Centre (IBC), Cambridge, England, 2001, in honour of an outstanding contribution in the field of ´Photobiology and Molecular Microbiology.

•Selected to review the Environmental Effects Assessment Panel report-2006 of United Nations Environmental Programme.

•Courses taught: Cell and Molecular Biology, Biochemical and Molecular Techniques and Bioinformatics, Photobiology and Molecular Biology of Cyanobacteria, Microbial Genomics, Microbiology, Plant Metabolism and Biochemistry, Biofertilizer Technology etc.

Dr. Rajeshwar Prasad SinhaMicrobiologist, BioTechnologist•Associate Professor, Laboratory of Photobiology and Molecular Microbiology, Centre of Advanced Study in Botany, Banaras Hindu University, Varanasi India. Industrial Microbiology.

•Selected as an Outstanding Scientist of the 21st century by International Biographical Centre (IBC), Cambridge, England, 2001, in honour of an outstanding contribution in the field of ´Photobiology and Molecular Microbiology.

•Selected to review the Environmental Effects Assessment Panel report-2006 of United Nations Environmental Programme.

•Courses taught: Cell and Molecular Biology, Biochemical and Molecular Techniques and Bioinformatics, Photobiology and Molecular Biology of Cyanobacteria, Microbial Genomics, Microbiology, Plant Metabolism and Biochemistry, Biofertilizer Technology etc.

BioChemistry / MicrobiologyBioChemistry / Microbiology

Mrs. Snehal Vijay More, M. Sc. Senior Researcher Microbiology

National Chemical Laboratory

Microbiology:

• Microbiological techniques like handling, isolations, maintenance of microorganisms,

• Fermentation

• Preservation of microbiological cultures

• Identification of microorganisms

Enzymology: Enzyme production,

• Protein extraction, purification

UV-Visible Spectroscopy, Chromatography

Mrs. Snehal Vijay More, M. Sc. Senior Researcher Microbiology

National Chemical Laboratory

Microbiology:

• Microbiological techniques like handling, isolations, maintenance of microorganisms,

• Fermentation

• Preservation of microbiological cultures

• Identification of microorganisms

Enzymology: Enzyme production,

• Protein extraction, purification

UV-Visible Spectroscopy, Chromatography

Pharmaceutical ChemistryPharmaceutical Chemistry

Dr. Rakesh Somani Pharmacist Senior Researcher, Professor

AREAS OF RESEARCH:

Green Chemistry and Microwave Synthesis, Heterocyclic Chemistry in anti-TB, anti-HIV and anti-cancer areas.

• Principal Collaborator for NIH, National Institute of Cancer (NCI), USA.

• Principal Collaborator for Rega Institute of Medical Research, Belgium.

Dr. Rakesh Somani Pharmacist Senior Researcher, Professor

AREAS OF RESEARCH:

Green Chemistry and Microwave Synthesis, Heterocyclic Chemistry in anti-TB, anti-HIV and anti-cancer areas.

• Principal Collaborator for NIH, National Institute of Cancer (NCI), USA.

• Principal Collaborator for Rega Institute of Medical Research, Belgium.

Engineering & Finance Engineering & Finance

Mr.Swapnil Maheshmale MBA, ME, BE MBA-Finance from Jamnalal Bajaj Institute of

Management, Masters of Engineering (ME-Mechanical) Automobile, Agricultural, Pharmaceutical Industries

• Pharmaceutical machinery design & development.• Agricultural Machinery • New Product Design, Research• Strategic planning • Special Interest in Financial Control, Project

management, Risk Management, Resource Planning in Pharmaceutical Machinery Development

Mr.Swapnil Maheshmale MBA, ME, BE MBA-Finance from Jamnalal Bajaj Institute of

Management, Masters of Engineering (ME-Mechanical) Automobile, Agricultural, Pharmaceutical Industries

• Pharmaceutical machinery design & development.• Agricultural Machinery • New Product Design, Research• Strategic planning • Special Interest in Financial Control, Project

management, Risk Management, Resource Planning in Pharmaceutical Machinery Development

Mechanical EngineeringMechanical Engineering

Mr. Rupesh Pimple, ME

• Mechanical Engineer with strong background in industrial engineering, factory operations production planning and quality management.

• Factory layout, systems efficiency calculations, operations including quality control, production and planning.

• Special interest in applying IT to industrial engineering operations.

Mr. Rupesh Pimple, ME

• Mechanical Engineer with strong background in industrial engineering, factory operations production planning and quality management.

• Factory layout, systems efficiency calculations, operations including quality control, production and planning.

• Special interest in applying IT to industrial engineering operations.

Mechanical Engineer, I.T.Mechanical Engineer, I.T.

Mr. Dinesh D. Gadekar ME

• A Mechanical/Production engineer with extensive management experience and over 10 years cross-functional experience in Vehicle Testing / Project Execution / Operation / Product Development and quality control and systems analysis.

• Proficiency in trials & tests for evaluation of newly developed parts /products. Deftness in developing need-based budgets while working with various vendors, Testing/Quality of firing I.C. Engines with BioFuels

• Special interest in Testing/ Project Execution/Operations/ Product Development

Mr. Dinesh D. Gadekar ME

• A Mechanical/Production engineer with extensive management experience and over 10 years cross-functional experience in Vehicle Testing / Project Execution / Operation / Product Development and quality control and systems analysis.

• Proficiency in trials & tests for evaluation of newly developed parts /products. Deftness in developing need-based budgets while working with various vendors, Testing/Quality of firing I.C. Engines with BioFuels

• Special interest in Testing/ Project Execution/Operations/ Product Development

BiotechnologyBiotechnology

Dr. Siddhivinayak. S. Barve BiotechnologistDistinctions: Gold Medalist at MSc, University of Mumbai

-Post Doctoral Programme in Transgenic Plants at the state-of-the-art Purdue University,USA-Executive Management Programme at prestigious Asian Institute of Management, Manila, Philippines-Reader & Head, Department of Botany and Coordinator, Department of Biotechnology and CPE Biotech Lab

Research Projects:Coordinator, Designed and Developed UGCCenter for Potential Excellence in Biotechnology-Research and Experimental Station for Medicinal Plants at India Institute of Technology -Coordinator, International Interdisciplinary Research ProjectIndia – EU Biotechnology Programme with university of Leiden, Netherlands and University of Dusseldorf-Jt Coodinator, Project of Bioremediation of lakes in Thane

Publications:-Authored 13 Books , published articles in journals, newspapers

Dr. Siddhivinayak. S. Barve BiotechnologistDistinctions: Gold Medalist at MSc, University of Mumbai

-Post Doctoral Programme in Transgenic Plants at the state-of-the-art Purdue University,USA-Executive Management Programme at prestigious Asian Institute of Management, Manila, Philippines-Reader & Head, Department of Botany and Coordinator, Department of Biotechnology and CPE Biotech Lab

Research Projects:Coordinator, Designed and Developed UGCCenter for Potential Excellence in Biotechnology-Research and Experimental Station for Medicinal Plants at India Institute of Technology -Coordinator, International Interdisciplinary Research ProjectIndia – EU Biotechnology Programme with university of Leiden, Netherlands and University of Dusseldorf-Jt Coodinator, Project of Bioremediation of lakes in Thane

Publications:-Authored 13 Books , published articles in journals, newspapers

Team ScientistsTeam Scientists

Biochemistry:

Dr. Veena Salvi

Engineering:

Mr. Satvindar

Biochemistry:

Dr. Veena Salvi

Engineering:

Mr. Satvindar

Sankalpa Executive TeamSankalpa Executive Team

• Sagar Sanawe, CEO Mr.Sanawe brings a wealth of

experience in management, project execution, engineering and design in the automotive and aerospace industry including design of BhraMos missile parts.

• Manager in thermal industries supervising production of large scale reactors, solid fuel boilers, heat exchangers, vessels and director of engineering teams in a wide range of applications.

• Sagar Sanawe, CEO Mr.Sanawe brings a wealth of

experience in management, project execution, engineering and design in the automotive and aerospace industry including design of BhraMos missile parts.

• Manager in thermal industries supervising production of large scale reactors, solid fuel boilers, heat exchangers, vessels and director of engineering teams in a wide range of applications.

Chief Operations OfficerChief Operations Officer

Poonam Gandhi, ME:

• Founding member, Sankalpa

• Systems and Operations Analysis• Strategic planning • Project management

• International Sales/Marketing.

• Mechanical Engineer with experience of product marketing, product management activities including product life cycle, market segment analysis

Poonam Gandhi, ME:

• Founding member, Sankalpa

• Systems and Operations Analysis• Strategic planning • Project management

• International Sales/Marketing.

• Mechanical Engineer with experience of product marketing, product management activities including product life cycle, market segment analysis

Synergy Synergy

Sankalpa’s team of scientists, engineers and advisors is growing rapidly, excited to optimize the

synergistic expertise of our world-class research capacity to lead the industry in the design, engineering, construction and operation of commercial facilities for species-adaptive

biotechnology.

Sankalpa’s team of scientists, engineers and advisors is growing rapidly, excited to optimize the

synergistic expertise of our world-class research capacity to lead the industry in the design, engineering, construction and operation of commercial facilities for species-adaptive

biotechnology.

In Closing In Closing

• Algae technology is perhaps the most important technology of our time. It will provide an abundant, fertile and self-developing source of protein, essential nutrients, medicine, fuel, fish feed and fertilizer, offering even the potential of a world without hunger.

• As a voracious “clean machine” for environmental remediation and carbon fixation, algae offers the key for capturing our CO2 overload, producing O2 and ensuring a viable environment for future generations.

• Algae technology is perhaps the most important technology of our time. It will provide an abundant, fertile and self-developing source of protein, essential nutrients, medicine, fuel, fish feed and fertilizer, offering even the potential of a world without hunger.

• As a voracious “clean machine” for environmental remediation and carbon fixation, algae offers the key for capturing our CO2 overload, producing O2 and ensuring a viable environment for future generations.

Global PotentialGlobal Potential

Despite climate change and natural resource exhaustion, we are led by the sheer force of algae science to the conclusion that algae has the capacity to solve virtually all of the pressing resource and environmental issues of our time, from “peak oil” to water supply to C02 sequestration. The potential for positive change, and profit, is limitless.

Algae Technology changes the playing field for our future.

Despite climate change and natural resource exhaustion, we are led by the sheer force of algae science to the conclusion that algae has the capacity to solve virtually all of the pressing resource and environmental issues of our time, from “peak oil” to water supply to C02 sequestration. The potential for positive change, and profit, is limitless.

Algae Technology changes the playing field for our future.

The missing link is the availability of commercially viable photoreactors and extraction machinery that will meet the challenges for algae biotechnology. They key is synergy in terms of

building the team and in developing the instrumentation.

The missing link is the availability of commercially viable photoreactors and extraction machinery that will meet the challenges for algae biotechnology. They key is synergy in terms of

building the team and in developing the instrumentation.

Missing Link: Biotechnology Missing Link: Biotechnology

With a start-up investment of 125 million dollars, the Sankalpa team of scientists and engineers will

produce biotechnology that will tap the global potential for algae resources and turn global

problems into profit and sustainability.

With a start-up investment of 125 million dollars, the Sankalpa team of scientists and engineers will

produce biotechnology that will tap the global potential for algae resources and turn global

problems into profit and sustainability.

Investment Investment

SANKALPA SANKALPA

Recovering the Future Recovering the Future

Algppt n0 v 13 11am2010

Documents